https://invesbrain.com/covid-19-wins-and-losses-genentechs-actemra-flunks-trial-vir-gsks-antibody-dazzles/
Covid-19 Wins and Losses: Genentech’s Actemra Flunks Trial; Vir & GSK’s Antibody Dazzles